| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Institute of Animal Physiology, the 2 Department for Equine Surgery, and the 3 Section of Immunobiology, Department of Ophthalmology, Ludwig-Maximilians University, Munich, Germany.
PURPOSE. To test the hypothesis that autoimmune mechanisms are involved in horses in which equine recurrent uveitis (ERU) develops spontaneously.
METHODS. Material obtained from horses treated for spontaneous disease by therapeutic routine vitrectomy was analyzed for total IgG content and IgG specific for S-Antigen (S-Ag) and interphotoreceptor retinoid-binding protein (IRBP). The cellular infiltrate of the vitreous was analyzed by differential counts of cytospin preparations and flow cytometry using equine lymphocyte-specific antibodies. Antigen-specific proliferation assays were performed comparing peripheral blood lymphocytes (PBLs) with vitreal lymphocytes by stimulation with S-Ag and several S-Ag– and IRBP-derived peptides.
RESULTS. The total IgG content of specimens from horses with ERU was very high with great variability among the investigated samples (11.5 ± 8.0 mg). Autoantibodies to S-Ag or IRBP or both were found in 72% of vitreous specimens from horses with uveitis. The leukocyte infiltrates (up to 2 x 108 cells per sample) were dominated by lymphocytes (>90%) in most cases (22/32). Flow cytometry showed that more than 50% of these cells were CD4+ T cells. In vitro stimulation of vitreal lymphocytes, but not of PBL, showed a strong proliferative response to peptides derived from S-Ag or IRBP in 9 of 12 patients.
CONCLUSIONS. In the eyes of horses with ERU, IgG antibodies and autoreactive T cells specific for retinal antigens were detected. These results strongly support the hypothesis that ERU is an autoimmune-mediated disease and is highly similar to recurrent uveitis in humans in both clinical and immunologic parameters.
This article has been cited by other articles:
|
|
 |
|
  C. A. Deeg, D. Pompetzki, A. J. Raith, S. M. Hauck, B. Amann, S. Suppmann, T. W. F. Goebel, U. Olazabal, H. Gerhards, S. Reese, et al. Identification and Functional Validation of Novel Autoantigens in Equine Uveitis Mol. Cell. Proteomics, August 1, 2006; 5(8): 1462 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Gilger, J. H. Salmon, D. A. Wilkie, L. P. J. Cruysberg, J. Kim, M. Hayat, H. Kim, S. Kim, P. Yuan, S. S. Lee, et al. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2596 - 2605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Deeg, B. Amann, A. J. Raith, and B. Kaspers Inter- and Intramolecular Epitope Spreading in Equine Recurrent Uveitis Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 652 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Verma, S. Artiushin, J. Matsunaga, D. A. Haake, and J. F. Timoney LruA and LruB, Novel Lipoproteins of Pathogenic Leptospira interrogans Associated with Equine Recurrent Uveitis Infect. Immun., November 1, 2005; 73(11): 7259 - 7266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Paglia, P. E. Miller, and R. R. Dubielzig James Wardrop and Equine Recurrent Uveitis Arch Ophthalmol, August 1, 2004; 122(8): 1218 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Deeg, S. Reese, H. Gerhards, G. Wildner, and B. Kaspers The Uveitogenic Potential of Retinal S-Antigen in Horses Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2286 - 2292. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
